Our results show that an increased SIRT1 expression in uterine cancer types (endometrioid and clear-cell) is correlated to a longer progression-free survival which supports the thesis that SIRT1 acts as a tumor suppressor. The gene discussed is SIRT1; the disease is neoplasm.